The Lancet Gastroenterology & Hepatology in conversation with
Ein Podcast von The Lancet Group
88 Folgen
-
Premysl Bercik on a double-blind crossover trial of gluten and wheat in IBS
Vom: 20.11.2025 -
Julia Mayerle on the validation of plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma
Vom: 19.6.2025 -
Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis
Vom: 9.4.2025 -
John Chia on the ASCOLT trial of adjuvant aspirin for colorectal cancer
Vom: 6.3.2025 -
Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes
Vom: 10.1.2025 -
Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn's disease small bowel strictures
Vom: 12.12.2024 -
Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis
Vom: 6.11.2024 -
Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease
Vom: 1.11.2024 -
Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer
Vom: 31.7.2024 -
Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy
Vom: 1.7.2024 -
Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS
Vom: 17.5.2024 -
Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease
Vom: 7.5.2024 -
Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa
Vom: 22.4.2024 -
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake
Vom: 12.3.2024 -
Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity
Vom: 1.3.2024 -
Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region
Vom: 19.12.2023 -
Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy
Vom: 29.11.2023 -
Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease
Vom: 12.10.2023 -
Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction
Vom: 13.9.2023 -
Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis
Vom: 10.8.2023
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
